- About Us
- Image Gallery
- Download Free
Published on : Saturday, February 6, 2016
On the heels of Miami International Airport being designated the first pharmaceuticals (pharma) freight hub in the Western Hemisphere last November, the airport hosted a seminar in conjunction with The Beacon Council and the Health Technologies and Distribution Alliance (HTDA) for more than 100 manufacturers, cargo logistics companies and other pharma stakeholders to discuss the state of the local industry. Pharma experts gave presentations on MIA’s pharma hub designation, best practices for transporting sensitive pharma products, current and projected demand for bio-pharmaceuticals, and the future impact on local business. Representatives from MIA, The Beacon Council, HTDA, the International Air Transport Association (IATA), American Airlines Cargo, Brinks Global Services, LAN Cargo and the University of Miami Health System were among the presenters.
“This workshop was a great opportunity to educate the community about our booming pharmaceuticals freight business,” said Miami-Dade Aviation Director Emilio T. González. “As the busiest U.S. airport for international freight, perishable imports and temperature-controlled products, MIA has been at the epicenter of this developing trend and is poised for even more growth.”
“MIA’s designation as a pharmaceutical freight hub will be the catalyst for growing pharma manufacturing and distribution in Miami-Dade County,” said The Beacon Council President and CEO Larry K. Williams. “Our ability to safely and securely transport pharma products to market underscores Miami’s competitive advantage with our trade and logistics infrastructure, foreign trade zone network and strong life sciences and aviation sectors.”
In 2015, IATA designated MIA as the first pharmaceuticals freight hub in the U.S. and only the second in the world, after Brussels Airport. The designation underscores MIA’s leading role as a safe and efficient global logistics hub for high-value, temperature-sensitive drugs and medicines. The total value of pharma products transported through MIA has increased by 79 percent since 2010 to $3.3 billion in 2014.
“Collaborative efforts like this workshop are beneficial to raise awareness of all important requirements, competencies, and factors related to pharmaceutical research development and distribution,” remarked Leandro Moreira, Brink’s Global Services Director of Life Sciences and HTDA Chairman. “It is clear that key stakeholders are taking a very disciplined and focused approach towards supporting pharmaceutical business development in the region. We are proud to partner with the Aviation Department and The Beacon Council to promote the growth of the local pharma industry.”